Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature
Mischelle A. Elliott, John A. Heit, Rajiv K. Pruthi, Dennis A. Gastineau, Jeffrey L. Winters, C. Christopher HookVolume:
83
Year:
2009
Language:
english
Pages:
8
DOI:
10.1111/j.1600-0609.2009.01292.x
File:
PDF, 102 KB
english, 2009